Published on 19 May 2024 on Simply Wall St. · via Yahoo Finance
We Think Some Shareholders May Hesitate To Increase 10x Genomics, Inc.'s...
Key Insights
10x Genomics to hold its Annual General Meeting on 11th of JuneTotal pay for CEO Serge Saxonov includes US$544.7k salaryTotal compensation is similar to the industry average 10x Genomics' EPS grew by 34% over the past three years while total shareholder loss over the past three years was 89%
The underwhelming share price performance of 10x Genomics, Inc. (NASDAQ:TXG) in the past three years would have disappointed many shareholders. However, what is unusual is that EPS growth has been positive, suggesting that the share price has diverged from fundamentals. These are some of the concerns that shareholders may want to bring up at the next AGM held on 11th of June. Voting on resolutions such as executive remuneration and other matters could also be a way to influence management. We discuss below why we think shareholders should be cautious of approving a raise for the CEO at the moment.